Peter Rahmer

Chief Corporate Development OfficeratRelay Therapeutics· In proxies 2022–2025

Pay in FY2025-69% from the year before · Relay Therapeutics stock +105.3% the same year

Peter Rahmer was paid $1.5M in FY2025 (Dec), down 69%. Relay Therapeutics stock rose 105.3% that year.

Pay$100 in the stock at the end of FY21 → $28

Pay is from the Summary Compensation Table of each Relay Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

Relay TherapeuticsPublic company · 4 yr
- Chief Corporate Development Officer2022 – Present · 4 yrStock in role -39%

Roles come from the proxy statements of each company.

Activity

Pay
Relay Therapeutics Chief Corporate Development Officer pay fell 69% to $1.5M. The stock rose 105% in FY2025 (Dec).
DEF 14AApr 28, 2026
Pay
Relay Therapeutics Chief Corporate Development Officer pay fell 27% to $5.0M. The stock fell 63% in FY2024 (Dec).
DEF 14AApr 23, 2025
Pay
Relay Therapeutics Chief Corporate Development Officer pay rose 179% to $6.8M. The stock fell 26% in FY2023 (Dec).
DEF 14AApr 23, 2024

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?